CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients

We aimed to identify hepatocellular carcinoma (HCC) patients who will respond to repetitive transarterial chemoembolization (TACE) to improve the treatment algorithm. Retrospectively, 61 patients (mean age, 65.3 years ± 10.0 [SD]; 49 men) with 94 HCC mRECIST target-lesions who had three consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernatz, Simon, Elenberger, Oleg, Ackermann, Jörg, Lenga, Lukas, Martin, Simon S., Scholtz, Jan-Erik, Koch, Vitali, Grünewald, Leon D., Herrmann, Yannis, Kinzler, Maximilian N., Stehle, Angelika, Koch, Ina, Zeuzem, Stefan, Bankov, Katrin, Doering, Claudia, Reis, Henning, Flinner, Nadine, Schulze, Falko, Wild, Peter J., Hammerstingl, Renate, Eichler, Katrin, Gruber-Rouh, Tatjana, Vogl, Thomas J., dos Santos, Daniel Pinto, Mahmoudi, Scherwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834236/
https://www.ncbi.nlm.nih.gov/pubmed/36631548
http://dx.doi.org/10.1038/s41598-023-27714-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834236/
https://www.ncbi.nlm.nih.gov/pubmed/36631548
http://dx.doi.org/10.1038/s41598-023-27714-0

Ejemplares similares